A Phase 2, Randomised, Double-Blind, Placebo-Controlled Study to Assess Efficacy and Safety of Multiple Dose Levels of Atuliflapon Given Orally Once Daily for Twelve Weeks in Adults with Moderate to Severe Uncontrolled Asthma.

Supported projects > Supported Project by Private Organizations in Other Countries · 2024

Authors: Özlem GÖKSEL

2024-2025, Supported Project by Private Organizations in Other Countries, R & D Project, Continues

View details